Survivin, another essential anti-apoptotic protein and an established marker of poor prognosis in colorectal carcinoma, has similarly been markedly reduced (52.2%) in the KAE-treated HT-29 group, compared to only 15.1% in cells exposed to cisplatin. Here, BIRC5 is linked to colorectal carcinoma.